Board of Advisors
At TranSenda, we work closely with an accomplished advisory board of industry experts to help refine our products and strategic direction. Drawing upon their extensive knowledge of healthcare and life sciences, TranSenda delivers solutions that are tailored to meet and exceed the specialized needs of our clients.
M.J. "Jay" Winship, M.D.
Darryl G. Barlett
Ruth Martens Scott
Board Members
M.J. "Jay" Winship, M.D.
Dr. Winship received his medical degree from Northwestern University Medical School. Further training included a rotating internship, a residency in Internal Medicine and a fellowship in Infectious Diseases. From 1972 to 1989, Dr. Winship was in private practice of Internal Medicine and Infectious Diseases. During this time, he was on the faculty of the Department of Internal Medicine at the University of Washington School of Medicine, the Department of Microbiology and Department of Pharmacy at University of Montana in Missoula, Department of Microbiology at Montana State University in Bozeman.
His credentials include board certification in Internal Medicine, Infectious Diseases, Medical Microbiology and Public Health Microbiology, and Geriatrics. He has been awarded Fellowships in the American Academy of Microbiology, American College of Physicians, and Infectious Diseases Society of America. Dr. Winship founded RMPC (Rocky Mountain Pus Club), the Teton Microbiology Lab in Idaho and headed the Infectious Diseases Center in Missoula (a non-profit multi-state medical and veterinarian microbial diagnostic laboratory).
Dr. Winship entered the pharmaceutical industry in 1989. He has conducted or participated in clinical trials for vaccines, antibodies, cancer, allergy, cytokines, and small molecules (caspase inhibitors). In addition, he has experience in medical affairs, filing INDs and NDAs. Dr. Winship has formulated and implemented a product compound development program from the benchtop into the clinic in a start-up and participated in the marketing development. In another small company he integrated the core competencies of drug and development in 3 separate therapeutic areas and participated in overall strategy.
He has given compound development lectures at SDSU's master degree program in regulatory affairs. Dr. Winship has evaluated potential products for commercial and licensing opportunities from numerous small and large companies.
Dr. Winship is currently the Chief Operating Officer and Chief Medical Officer for Light Sciences Oncology, Inc. in Snoqualmie, Washington.
Darryl G. Barlett
As Managing Director of Quality Business Solutions (QBS), Darryl Barlett uniquely combines 28 years of practical experience in information systems management, application software product development, business process improvements, project management and consulting with special emphasis in the healthcare and life sciences industries.
Mr. Barlett is a graduate of the University of Akron in Ohio, where he obtained his degrees in Accounting and Business Administration. He is also a graduate of the respected Wharton Business School. Darryl is the former Vice President and Corporate Director of Information Systems for two Fortune 500 corporations--Goodyear Tire & Rubber Corporation and Warner Lambert/Parke Davis where he provided the hands-on leadership to develop and implement global business support systems.
As the former EVP and CIO of two industry leading healthcare companies, Darryl brings firsthand knowledge in industry-wide applications software evaluations and selection, software product development, change management, enterprise-wide systems integration and governmental regulations. As the founder of two information services consulting companies, Mr. Barlett has provided the visionary leadership to build, grow and cultivate these highly respected and profitable consulting firms.
Darryl has been responsible for leading the successful design, development and implementation of multiple Healthcare and Life Sciences related technology initiatives including a JD Powers award-winning claims processing, billing and reimbursement system. This system was later licensed to and branded by five of the largest claims processing clearinghouses in the US.
As a former member of the Society of Quality Assurance and the association's Computer Validation Initiative Committee, Darryl led the project which produced the first successful FDA-compliant clinical trials tracking system. This system is recognized within the industry for its level of quality and data integrity safeguards.
Darryl has been nationally recognized by The American Institute of Information Technology, ComputerWorld and the American Society for Quality Control (ASQC) as one of the industries leading business performance and information systems consultants, helping client organizations improve revenues, increase market share, and reduce operating expenses through information systems technology, process reengineering, business systems solutions, project management and business leadership.
Ruth Martens Scott
As President of the Washington Biotechnology & Biomedical Association (WBBA) for almost seven years, Ruth Martens Scott led the WBBA into being one of the most respected state life science associations in the country. During her tenure the Association doubled its membership and tripled its revenues, hosted the international BIO’99 biotechnology conference, and completed the seminal economic impact analysis for the state’s bioscience sector. WBBA’s expanded membership includes the state’s research institutions, biotechnology and medical device companies, contract research organizations, economic development offices, and many firms doing business with the life sciences. Scott is credited with introducing signature events, such as Invest Northwest, Bioscience Day in Olympia, and summer socials. Under her leadership, WBBA became the primary voice for the life sciences sector in Washington State, especially in public advocacy at the city, state and federal levels.
In recognizing Scott as one of the region’s “Newsmakers of 2004”, the Puget Sound Business Journal stated that “the state will lose one of its strongest advocates for its fledgling life-sciences sector” when she leaves her post in early 2005. In an article announcing her retirement, The Seattle Times referred to Scott as “Biotech’s godmother.”
While at WBBA, Scott was a member of the Technology Alliance Board of Directors, the Biotechnology Industry Organization (BIO), the Executive Committee of the Council of State Bioscience Associations, and Washington State University’s College of Sciences Board of Visitors. Governor Locke appointed her to the BIO 21 Steering Committee, which resulted in the Life Sciences Discovery Fund.
Scott’s previous work experience included seventeen years with the American Cancer Society (ACS), including six as chief executive officer for the Washington Division. Among her accomplishments was the development of the Relay for Life from a small local fundraiser to an international signature event for the American Cancer Society. She was a driving force behind the ACS/State Department of Health tobacco control grant, which resulted in funding from the National Cancer Institute. In support of ACS breast cancer awareness programs, Scott provided the stimulus for a statewide low-cost mammography project and legislation providing insurance coverage for mammograms.
Currently, Scott is chair-elect of the board of directors for the Arthritis Foundation’s Pacific Northwest Chapter.
